Beth Israel Deaconess Medical Center Inc.

UEI
SXSANHCVBJH1
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
0 micro-computed tomography scans HHSN2672006MK602979P National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $2,760

Grant awards

Award Agency Obligated Awarded
Chemical genetic analysis of platelet granule secretion R03DA026209 National Institutes of Health $25,000
Language and cardiovascular risk factor screening and control in U.S. Hispanics F32HL091684 National Institutes of Health $61,586
Impact of opiates on cellular immune responses in HIV/HCV infection R03DA023888 National Institutes of Health $85,000
Mucosal protection against HIV transmission by combinations of anti-HIV antibodie R21AI075932 National Institutes of Health $212,500
Structure-based in silico screen for small molecule inhibitors of ETS-1 activity R21AR054442 National Institutes of Health $252,840

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Beth Israel Deaconess Medical Center Inc. registered in SAM.gov?

Beth Israel Deaconess Medical Center Inc.'s SAM.gov registration expired on December 6, 2005.

What is Beth Israel Deaconess Medical Center Inc.'s most recent federal award?

Beth Israel Deaconess Medical Center Inc.'s most recent federal grant award is Chemical genetic analysis of platelet granule secretion (R03DA026209), from National Institutes of Health, on June 1, 2008.

On GovTribe

See Beth Israel Deaconess Medical Center Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login